Be Familiar With the New Viral Vector Vaccine for COVID-19

March 2021

You'll hear buzz about the new "viral vector" COVID-19 vaccine from Johnson & Johnson/Janssen (Ad26.COV2.S).

Viral vector COVID-19 vaccines give our cells instructions to make the SARS-CoV-2 spike protein, to trigger an immune response...similar to the mRNA COVID-19 vaccines from Pfizer-BioNTech or Moderna.

But they do it in different ways. The mRNA vaccines give our cells an mRNA blueprint. Johnson & Johnson's COVID-19 vaccine delivers instructions using a harmless adenovirus as a "vector," or carrier.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Be Familiar With the New Viral Vector Vaccine for COVID-19
Immunizations Reduce the Risk of Pain or Injury From IM Vaccinations
Mental Health Use Strategies to Keep Stress at Bay
Overactive Bladder Think of Gemtesa as Similar to Myrbetriq for Overactive Bladder
Opioids Stay Vigilant When Dispensing Fentanyl Rxs
HIV & AIDS Watch for Cabenuva, a New Monthly Injectable for HIV
Pediatrics Don't Kid Around With Pediatric Rxs
Asthma Expect Some Patients to Get One Inhaler to Prevent AND Relieve Asthma Attacks
Headache Ask if Emgality Is Being Used for Cluster Headaches or Migraine

Be Familiar With the New Viral Vector Vaccine for COVID-19

Practical advice for a better career, with unlimited access to CE

Table of Contents